Danaher Corporation (0R2B.L)
USD 192.25
(3.1%)
USD 192.25
(3.1%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 5.38 Billion USD | -28.6% |
| 2022 | 7.53 Billion USD | -6.39% |
| 2021 | 8.05 Billion USD | 86.69% |
| 2020 | 4.31 Billion USD | 28.24% |
| 2019 | 3.36 Billion USD | 9.52% |
| 2018 | 3.07 Billion USD | -2.52% |
| 2017 | 3.14 Billion USD | 5.43% |
| 2016 | 2.98 Billion USD | 28.39% |
| 2015 | 2.32 Billion USD | 7.5% |
| 2014 | 2.16 Billion USD | -32.81% |
| 2013 | 3.22 Billion USD | 0.1% |
| 2012 | 3.21 Billion USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 1.16 Billion USD | -10.98% |
| 2024 Q1 | 1.31 Billion USD | -7.21% |
| 2024 Q3 | 958 Million USD | -17.98% |
| 2023 Q4 | 1.41 Billion USD | -1.67% |
| 2023 FY | 5.27 Billion USD | -29.95% |
| 2023 Q1 | 1.79 Billion USD | -22.17% |
| 2023 Q2 | 1.42 Billion USD | -20.35% |
| 2023 Q3 | 1.43 Billion USD | 0.63% |
| 2022 FY | 7.53 Billion USD | -6.39% |
| 2022 Q4 | 2.3 Billion USD | 14.39% |
| 2022 Q3 | 2.01 Billion USD | -8.62% |
| 2022 Q2 | 2.2 Billion USD | 1.52% |
| 2022 Q1 | 2.17 Billion USD | 0.84% |
| 2021 Q1 | 2.03 Billion USD | 16.13% |
| 2021 Q2 | 2 Billion USD | -1.57% |
| 2021 Q3 | 1.88 Billion USD | -6.03% |
| 2021 Q4 | 2.15 Billion USD | 14.33% |
| 2021 FY | 8.05 Billion USD | 86.69% |
| 2020 Q3 | 1.32 Billion USD | 26.77% |
| 2020 Q4 | 1.75 Billion USD | 32.28% |
| 2020 FY | 4.31 Billion USD | 28.24% |
| 2020 Q1 | 711 Million USD | -25.86% |
| 2020 Q2 | 1.04 Billion USD | 47.12% |
| 2019 FY | 3.36 Billion USD | 9.52% |
| 2019 Q4 | 959 Million USD | 22.87% |
| 2019 Q3 | 780.5 Million USD | -4.43% |
| 2019 Q2 | 816.7 Million USD | 12.68% |
| 2019 Q1 | 724.8 Million USD | 16.23% |
| 2018 FY | 3.07 Billion USD | -2.52% |
| 2018 Q2 | 875.8 Million USD | 16.65% |
| 2018 Q4 | 623.6 Million USD | -25.74% |
| 2018 Q3 | 839.8 Million USD | -4.11% |
| 2018 Q1 | 750.8 Million USD | -32.08% |
| 2017 Q2 | 676.7 Million USD | 8.46% |
| 2017 Q1 | 623.9 Million USD | -33.77% |
| 2017 FY | 3.14 Billion USD | 5.43% |
| 2017 Q4 | 1.1 Billion USD | 44.03% |
| 2017 Q3 | 767.5 Million USD | 13.42% |
| 2016 Q2 | 710.1 Million USD | 15.82% |
| 2016 Q1 | 613.1 Million USD | -24.87% |
| 2016 Q3 | 699.1 Million USD | -1.55% |
| 2016 FY | 2.98 Billion USD | 28.39% |
| 2016 Q4 | 942 Million USD | 34.74% |
| 2015 FY | 2.32 Billion USD | 7.5% |
| 2015 Q4 | 816.1 Million USD | 70.02% |
| 2015 Q3 | 480 Million USD | 74.23% |
| 2015 Q2 | 275.5 Million USD | -63.51% |
| 2015 Q1 | 755.1 Million USD | -25.55% |
| 2014 FY | 2.16 Billion USD | -32.81% |
| 2014 Q4 | 1.01 Billion USD | 17.09% |
| 2014 Q1 | 788.9 Million USD | -20.69% |
| 2014 Q3 | 866.2 Million USD | 5.03% |
| 2014 Q2 | 824.7 Million USD | 4.54% |
| 2013 Q3 | 812.4 Million USD | -3.7% |
| 2013 Q2 | 843.6 Million USD | 15.42% |
| 2013 FY | 3.22 Billion USD | 0.1% |
| 2013 Q1 | 730.9 Million USD | -13.41% |
| 2013 Q4 | 994.7 Million USD | 22.44% |
| 2012 Q4 | 844.1 Million USD | 0.0% |
| 2012 FY | 3.21 Billion USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Phreesia, Inc. | -131.77 Million USD | 4183.538% |
| Accuray Incorporated | 504 Thousand USD | -1067558.73% |
| Align Technology, Inc. | 643.33 Million USD | -736.419% |
| Elevance Health Inc. | 133.96 Billion USD | 95.983% |
| AxoGen, Inc. | -21.46 Million USD | 25172.221% |
| Boston Scientific Corporation | 2.34 Billion USD | -129.663% |
| CVS Health Corporation | 13.74 Billion USD | 60.846% |
| Cardinal Health, Inc. | 1.24 Billion USD | -332.904% |
| Centene Corporation | 2.93 Billion USD | -83.652% |
| DaVita Inc. | 1.6 Billion USD | -235.728% |
| HCA Healthcare, Inc. | 9.62 Billion USD | 44.105% |
| Hologic, Inc. | 970.2 Million USD | -454.628% |
| Humana Inc. | 4.01 Billion USD | -34.089% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -390.462% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | -641.593% |
| Masimo Corporation | 136.5 Million USD | -3842.125% |
| McKesson Corporation | 3.9 Billion USD | -37.657% |
| Patterson Companies, Inc. | 252.92 Million USD | -2027.517% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | -326.387% |
| ResMed Inc. | 1.31 Billion USD | -307.685% |
| Henry Schein, Inc. | 615 Million USD | -774.959% |
| Teladoc Health, Inc. | -248.55 Million USD | 2264.931% |
| Universal Health Services, Inc. | 1.17 Billion USD | -357.809% |
| Veeva Systems Inc. | 429.33 Million USD | -1153.337% |
| Baxter International Inc. | 390 Million USD | -1279.744% |
| Becton, Dickinson and Company | 2.11 Billion USD | -154.903% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | -204.562% |
| Stryker Corporation | 3.88 Billion USD | -38.4% |
| Medtronic plc | 5.14 Billion USD | -4.607% |